Keith Bush
@thoreval.bsky.social
Quantitative horseplayer 🇭🇰 | Machine learning and analytics @horseracingnation.bsky.social | HKultra admin.
Reposted by Keith Bush
Check out my new publication in journals.physiology.org
on #ozempic and #cancer. GLP-1 receptor agonists are fundamentally a type of caloric restriction and we predict strong anti-cancer effects in diabetics. But what about cachexia? journals.physiology.org/doi/abs/10.1...
on #ozempic and #cancer. GLP-1 receptor agonists are fundamentally a type of caloric restriction and we predict strong anti-cancer effects in diabetics. But what about cachexia? journals.physiology.org/doi/abs/10.1...
GLP-1 Receptor Agonists in the Context of Cancer – The Road Ahead | American Journal of Physiology-Cell Physiology | American Physiological Society
A rapidly increasing proportion of the population in the United State is taking Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs) for type 2 diabetes (T2D) or weight loss. Consequently, an increasi...
journals.physiology.org
April 28, 2025 at 3:02 PM
Check out my new publication in journals.physiology.org
on #ozempic and #cancer. GLP-1 receptor agonists are fundamentally a type of caloric restriction and we predict strong anti-cancer effects in diabetics. But what about cachexia? journals.physiology.org/doi/abs/10.1...
on #ozempic and #cancer. GLP-1 receptor agonists are fundamentally a type of caloric restriction and we predict strong anti-cancer effects in diabetics. But what about cachexia? journals.physiology.org/doi/abs/10.1...